Covid Vaccine Breaking News: Judge Blocks D.C. Law That Allowed Children To Receive Vaccination With No Parent Consent

Covid Vaccine Breaking News: Judge Blocks D.C. Law That Allowed Children To Receive Vaccination With No Parent Consent

The covid vaccines are making headlines again, as you can see. This time it’s about the covid vaccine for kids with no parents’ approval. 

It’s been just reported that according to the latest reports, a federal judge temporarily blocked a Washington, D.C., law from going into effect that would have allowed children as young as 11 years old to receive covid vaccination without parental consent.

Judge Trevor McFadden ruled that the Minor Consent for Vaccinations Amendment Act of 2020 (MCA) “targets religious parents.”

“States and the District are free to encourage individuals — including children — to get vaccines.”

This is what McFadden wrote in his ruling.

“But they cannot transgress on the [National Childhood Vaccine Injury Act] Congress created. And they cannot trample on the Constitution.”

The ruling addressed two separate lawsuits that have been filed in July.

“In one complaint, a group of parents with children enrolled in city public or charter schools argued Washington Mayor Muriel Bowser could not enforce the law because it subverts the right and duty of parents to make informed decisions about whether their children should receive vaccinations.”

This is what the Washington Examiner reported.

AstraZeneca covid breaking news 

The other day, we revealed that the press agency Reuters just noted that AstraZeneca said on Monday its antibody-based cocktail to prevent and treat covid 19 retained neutralizing activity against Omicron coronavirus variants, including the highly contagious BA.2 sub-variant, in an independent lab study.

At the end of 2021, we were revealing that there are more and more predictions about the path that the pandemic will be taking in the near future. Now, it’s been revealed that brand new studies are addressing the efficiency of AstraZeneca’s monoclonal antibody drugs.

It’s been just revealed that the drug is effective against the covid 19 variant Omicron, according to a new report.

“The company’s EVUSHELD retains neutralization activity against omicron, according to ‘live’ virus neutralization data from both University College Oxford and Washington University School of Medicine,” ABC News reported.

Check out our previous article in order to learn more details. 

Rada Mateescu

Passionate about freedom, truth, humanity, and subjects from the science and health-related areas, Rada has been blogging for about ten years, and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.